本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Redhill Biopharma Ltd

2.00
+0.02001.01%
盤後1.92-0.0800-4.00%16:21 EDT
成交量:8,059.00
成交額:1.61萬
市值:350.40萬
市盈率:-0.30
高:2.03
開:1.99
低:1.94
收:1.98
資料載入中...
2019/08/06

SEC問詢函

[Cover]Correspondence
2019/07/24

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/07/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/17

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/15

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]